Stelac Advisory Services’s iShares Biotechnology ETF IBB Stock Holding History
Bought
Maintained
Sold
Other funds holding IBB
Stelac Advisory Services's IBB Position: Q3 2026 in Review
Stelac Advisory Services opened a new position in iShares Biotechnology ETF (IBB) in Q3 2026: 500 shares worth $105K. The stake represents 0.02% of the portfolio and ranks #162 among its holdings. This is a return to the name: Stelac Advisory Services previously reported a position in IBB as recently as Q4 2020.
Stelac Advisory Services first reported a position in IBB in Q4 2020 and has held it in 2 quarters since. The position peaked at $136K in Q4 2020. 700 funds tracked by Wall St. Rank hold IBB as of Q3 2026.
- Stelac Advisory Services held 500 shares of iShares Biotechnology ETF worth $105K as of Q3 2026.
- iShares Biotechnology ETF was a new Stelac Advisory Services position in Q3 2026.
- iShares Biotechnology ETF made up 0.02% of Stelac Advisory Services's portfolio in Q3 2026, its #162 holding.
- Stelac Advisory Services first reported a position in iShares Biotechnology ETF in Q4 2020 and has held it in 2 quarters since.
- Stelac Advisory Services's iShares Biotechnology ETF position peaked at $136K in Q4 2020.
- 700 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q3 2026.
Based on Stelac Advisory Services's 13F filing for Q3 2026, filed 10 Nov 2026.